Dow Jones and Tekmira Pharmaceuticals

Tekmira Pharmaceuticals: The tech-heavy Nasdaq index added 0.02%, or 0.74 points, at 4,402.07. , according to BBC. Tekmira Pharmaceuticals, a company working on a treatment for the Ebola virus, was down 17%. It had risen 68% since 7 August, when US regulators allowed it to test its experimental drug in people with the virus. The Dow Jones was a meagre 0.01% higher, or 1.86 points, at 16,571.84, while the broader S P 500 was up 0.06%, or 1.22 points, at 1938.14. Shares in the handbag-maker Kate Spade jumped 9% after the company reported better than expected earnings and revenue. (news.financializer.com). As reported in the news.